| Health / Medical Topics |
TARP 27-35 Peptide Vaccine
A peptide-based cancer vaccine, containing amino acid residues 27 through 35 of T cell receptor gamma alternate reading frame protein (TARP), with potential immunostimulatory and antineoplastic activities. Upon administration, TARP 27-35 peptide vaccine may stimulate a host cytotoxic T-cell (CTL) response against TARP-expressing tumor cells, resulting in tumor cell cytotoxicity. The nuclear protein TARP is commonly expressed on prostate and breast cancer cells and is highly immunogenic. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance that is being studied in the treatment of cancer. It may help tumor cells respond again to drugs they have…
A hydrochloride salt form of taribavirin, an orally available prodrug of ribavirin, a synthetic nucleoside analog of ribofuranose with activity against a…
An orally available prodrug of ribavirin, a synthetic nucleoside analog of ribofuranose with activity against a wide range of viruses, especially the…
A drug used to treat skin problems caused by cutaneous T-cell lymphoma that have not gotten better after other treatment. It is…
A red, edematous ring skin finding that may have a central dusky disk and an erythematous halo.
The process of directing an agent to a specific anatomic location.
